2021 House Bill 4354

Impose oral chemotherapy insurance mandate

Introduced in the House

Feb. 24, 2021

Introduced by Rep. Daire Rendon (R-103)

To impose a new coverage mandate that would require insurance companies to include coverage for orally administered chemotherapy in all their health insurance policies that provide for cancer chemotherapy treatments, without requiring any dollar limit, deductible or co-pay for these that does not apply to other treatments.

Referred to the Committee on Insurance

March 18, 2021

Reported without amendment

With the recommendation that the substitute (H-1) be adopted and that the bill then pass.

March 24, 2021

Passed in the House 91 to 15 (details)

To impose a new coverage mandate that would require insurance companies to include coverage for orally administered chemotherapy in all their health insurance policies that provide for cancer chemotherapy treatments, without requiring any dollar limit, deductible or co-pay for these that does not apply to other treatments. Also, to ban charging a copay of more than $150 per month on these drugs.

Received in the Senate

March 25, 2021

Referred to the Committee on Health Policy and Human Services